Skip to main content
Clinical Trials/ACTRN12612000152820
ACTRN12612000152820
Recruiting
Phase 4

The incidence of infection and obstruction of newly inserted permanent tunneled dialysis catheters in chronic hemodialysis patients with using alteplase or trisodium citrate as a locking solution after the middle hemodialysis procedure.

Pavlina Richtrova, MD, PhD0 sites80 target enrollmentFebruary 3, 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
The incidence of infection and obstruction of permanent tunneled dialysis catheters
Sponsor
Pavlina Richtrova, MD, PhD
Enrollment
80
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Pavlina Richtrova, MD, PhD

Eligibility Criteria

Inclusion Criteria

  • Patients with end stage kidney disease and newly inserted permanent tunneled dialysis catheter. Dialysis prescription \= 3 times a week. Agreement with the trial participation.

Exclusion Criteria

  • \- anticoagulation treatment INR more than 1\.4
  • \- platelets count less than 60x109/l
  • \- catheter insertion in vena cava inferior region (femoral vein)
  • \- catheter insertion by a guide\-wire exchange procedure
  • \- active pericarditis with pericardial effusion
  • \- known allergy or intolerance to alteplase or trisodium
  • \- citrate pregnancy or breast\-feeding

Outcomes

Primary Outcomes

Not specified

Similar Trials